EligibleTrials

AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation

Recruiting · NCT05776797 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital Ostrava

View the official record on ClinicalTrials.gov →
Atrial fibrillation

Interventions studied

Atrioventricular junction ablation in patients with cardiac resynchronization therapy (CRT)Optimal medication treatment in patients with cardiac resynchronization therapy (CRT)

What this trial is about

A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.

Who can take part

Age range
18 Years to 85 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

9 locations listed.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.